End Cash: The amount of cash held by the company for the given period.
Arcutis Biotherapeutics, Inc. (ARQT) had End Cash of $53.72M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$65.85M |
|
$-25.06M |
|
$8.83M |
|
$57.02M |
|
$90.38M |
|
$-24.53M |
|
$-0.25M |
|
$-24.78M |
|
$-24.78M |
|
$-25.06M |
|
$-25.06M |
|
$-25.06M |
|
$-25.06M |
|
$-24.53M |
|
$-22.26M |
|
126.04M |
|
126.04M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$323.67M |
|
$1.50M |
|
$20.43M |
|
$344.11M |
|
$91.13M |
|
$107.62M |
|
$110.32M |
|
$201.45M |
|
$142.66M |
|
$126.16M |
|
$142.66M |
|
119.14M |
|
| Cash Flow Statement Financials | |
$-30.38M |
|
$11.75M |
|
$0.40M |
|
$71.95M |
|
|
End Cash |
$53.72M |
$-18.23M |
|
$9.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.55 |
|
-- |
|
-- |
|
0.43 |
|
0.75 |
|
86.59% |
|
-37.25% |
|
-37.25% |
|
-- |
|
-37.63% |
|
-38.06% |
|
$-30.99M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.53 |
|
0.77 |
|
116.75 |
|
-17.57% |
|
-19.86% |
|
-7.28% |
|
-10.01% |
|
$1.20 |
|
$-0.25 |
|
$-0.24 |
|